Table 1.

Characteristics of the patients at enrollment and 10 years after achieving remission. Values are n (%) unless otherwise specified.

VariableAt EnrollmentAt 10 Yrs after Remission
Females24 (88.9)
Age at SLE diagnosis, yrs, mean ± SD39.03 ± 14.06
Ethnicity
  White21 (77.8)
  Black2 (7.4)
  Others4 (14.8)
SLEDAI-2K, mean ± SD10.67 ± 11.571.2 ± 1.6
C3/C49 (33.3)8 (29.6)
Anti-dsDNA+13 (48.1)6 (22.2)
Anti-SSA/Ro8 (29.6)7 (25.9)
Anti-SSB/La3 (11.1)2 (7.4)
Anti-Sm2 (7.4)2 (7.4)
Anti-RNP3 (11.1)4 (14.8)
Glucocorticosteroids17 (63)6 (22.2)
Prednisone dose, mg/day, mean ± SD16.8 ± 9.55.3 ± 3.2
Antimalarials16 (59.3)11 (40.7)
Immunosuppressives9 (33.3)3 (11.1)
SLICC/DI, at 1 yr, mean ± SD0.26 ± 0.530.96 ± 1.06
SLICC/DI > 0, at 1 yr8 (29.6)16 (59.3)
  • SLE: systemic lupus erythematosus; SLEDAI-2K: Systemic Lupus Erythematosus Disease Activity Index 2000; SLICC/DI: Systemic Lupus International Collaborating Clinics/Damage Index.